Biotech is set for a geopolitical stress test
Skip to main content
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Splash
  • Features
  • Videos
  • Long Read
  • Games
  • Epaper
  • More
    • COVID-19
    • Bangladesh
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Subscribe
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
The Business Standard
THURSDAY, MAY 26, 2022
THURSDAY, MAY 26, 2022
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Splash
  • Features
  • Videos
  • Long Read
  • Games
  • Epaper
  • More
    • COVID-19
    • Bangladesh
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Subscribe
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
Biotech is set for a geopolitical stress test

Tech

Reuters
15 January, 2022, 12:30 pm
Last modified: 15 January, 2022, 01:02 pm

Related News

  • China, US are racing to make billions from mining the moon's minerals
  • US accuses casino tycoon Wynn of acting as Chinese agent
  • ‘The geopolitical landscape is undergoing profound change, Dhaka needs to craft proactive strategies’
  • US calls out Russia, China opposition to UN action on N Korea
  • Rising military spending in the ‘return of geopolitics’

Biotech is set for a geopolitical stress test

Chinese entrepreneurs who moved abroad are coming home to find favourable government policies and ample funding awaiting

Reuters
15 January, 2022, 12:30 pm
Last modified: 15 January, 2022, 01:02 pm
A medical worker prepares to administer a dose of a coronavirus disease (Covid-19) vaccine to a woman at a vaccination site, during a government-organised visit, following the coronavirus disease (Covid-19) outbreak, in Shanghai, China, 19 January, 2021. PHOTO: REUTERS/Aly Song
A medical worker prepares to administer a dose of a coronavirus disease (Covid-19) vaccine to a woman at a vaccination site, during a government-organised visit, following the coronavirus disease (Covid-19) outbreak, in Shanghai, China, 19 January, 2021. PHOTO: REUTERS/Aly Song

Diseases have no borders, but biotechnology companies do. The sector has been immune to US-China tensions so far, but political risks are building.

The industry is entering a golden age in the People's Republic. Chinese entrepreneurs who moved abroad are coming home to find favourable government policies and ample funding awaiting. Rising mRNA technology star Suzhou Abogen Biosciences, led by a former Moderna scientist, raised over $1 billion last year alone from backers like SoftBank's Vision Fund and Temasek. Consulting firm ChinaBio reckons investments into Chinese healthcare hit $38 billion in 2021, up by a third from the previous year.

International partnerships have buoyed rising stars like $27 billion BeiGene. Founded in China over a decade ago, the group boasts three listings in Shanghai, Hong Kong and New York, and three global headquarters; it operates in over 20 countries. It unveiled an up-to-$1 billion agreement with Novartis for its innovative cancer treatment in late December. Of the 500-plus pharmaceutical and biotech collaborations in China in 2021, over 60% were cross-border, according to November data from ChinaBio.

It's a pleasant contrast to the dramatic financial decoupling underway in China's technology sector, prompted by diplomatic spats over accounting oversight, national security and other issues.

Markets are worried Chinese biotech's exception won't last. A media report that the industry might be targeted by US sanctions triggered a huge selloff in December. Contract drugmaker Wuxi BioLogics, which generated over 50% of its first-half revenue in North America, shed over $10 billion in market value in a single day; BeiGene's Shanghai stock tumbled 16% on their debut.

Nothing has come of the rumours so far, but the sector is vulnerable. Companies that don't allow American regulators to inspect their audit work for three years can be kicked off New York bourses, putting BeiGene's Wall Street ticker at risk. In December, Beijing updated its list of sectors where foreign investment is banned or restricted, and left gene diagnostics and therapeutic technologies on it. That forces companies developing promising treatments like US-listed Legend Biotech to rely on complex tenuous workarounds. A geopolitical stress test looks imminent.

Top News / World+Biz / China

Biotechnology / geopolitics / Chinese Technology / US-China Tensions

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Wheat stock at 3-year low and that may not be good for rice
    Wheat stock at 3-year low and that may not be good for rice
  • Ousted Pakistani Prime Minister Imran Khan gestures as he travels on a vehicle to lead a protest march in Islamabad, Pakistan May 26, 2022. REUTERS/Akhtar Soomro
    Azadi March: Imran gives 6-day ultimatum to announce polls
  • VAT on locally-made mobile phones, fridges on cards
    VAT on locally-made mobile phones, fridges on cards

MOST VIEWED

  • Samsung Electronics Vice Chairman, Jay Y Lee, leaves the Seoul high court in Seoul, South Korea, October 25, 2019. REUTERS/Kim Hong-Ji
    Samsung boss Lee hosts Biden, Yoon in tour of S Korea chip plant
  • A smartphone with the Huawei and 5G network logo is seen on a PC motherboard in this illustration picture taken 29 January 2020. Photo:REUTERS
    Canada to ban Huawei/ZTE 5G equipment, joining Five Eyes allies
  • Software programmers walk out of the International Technology Park Ltd (ITPL) building which houses nearly 50 technology firms in Bangalore. Photo: Reuters
    JPMorgan downgrades India's IT sector as Covid boom fades
  • Photo: PR
    Grameenphone launches 'GP Academy' in partnership with Telenor and Cisco
  • FILE PHOTO: An image of Elon Musk is seen on a smartphone placed on printed Twitter logos in this picture illustration taken April 28, 2022. REUTERS/Dado Ruvic/Illustration
    Elon Musk can't easily give Twitter the boot over bots
  • A China-made Tesla Model 3 electric vehicle is seen ahead of the Guangzhou auto show in Guangzhou, Guangdong province, China November 21, 2019. Photo :Reuters
    China in talks with automakers on EV subsidy extension -sources

Related News

  • China, US are racing to make billions from mining the moon's minerals
  • US accuses casino tycoon Wynn of acting as Chinese agent
  • ‘The geopolitical landscape is undergoing profound change, Dhaka needs to craft proactive strategies’
  • US calls out Russia, China opposition to UN action on N Korea
  • Rising military spending in the ‘return of geopolitics’

Features

Impact Hub Dhaka is designed to cater to connectivity, offering lots of communal areas where you can chat over coffee, watch a webinar as a group or even host events. Photo: Courtesy

Inside Impact Hub: The surprising benefits of working in a co-working space

14m | Pursuit
Pacific Jeans uses sustainable technology in washing and finishing, and now has the facility to wash with zero water. Photo: Courtesy

How big dreams and smart investment made Pacific Jeans a denim exporting giant 

1h | Panorama
Psycure has received various awards for their extraordinary contributions to promoting Sustainable Development Goals. Photo: Courtesy

Psycure: Meet the organisation serving the underserved university students (and beyond) with mental healthcare 

23h | Panorama
Underlying problems such as school dropouts need to be addressed first before taking a legal route to stop child labour. Photo: Reuters

‘Child labour in a country like Bangladesh is primarily a development issue, not so much of enforcement’

1d | Panorama

More Videos from TBS

Tea tales at TSC

Tea tales at TSC

39m | Videos
What journalism students want to know

What journalism students want to know

1h | Videos
Where the people have more weapons than military

Where the people have more weapons than military

11h | Videos
Govt plans to amnesty in the offing to bring back laundered money to meet dollar crises

Govt plans to amnesty in the offing to bring back laundered money to meet dollar crises

14h | Videos

Most Read

1
Tk100 for bike, Tk2,400 for bus to cross Padma Bridge
Bangladesh

Tk100 for bike, Tk2,400 for bus to cross Padma Bridge

2
Bangladesh at risk of losing ownership of Banglar Samriddhi
Bangladesh

Bangladesh at risk of losing ownership of Banglar Samriddhi

3
BSEC launches probe against Abul Khayer Hero and allies
Stocks

BSEC launches probe against Abul Khayer Hero and allies

4
Photo: Courtesy
Panorama

Misfit Technologies: A Singaporean startup rooted firmly in Bangladesh

5
Illustration: TBS
Banking

Let taka slide

6
Photo: Collected
Industry

Spanish recycled cotton producer opens new facility in Bangladesh

The Business Standard
Top
  • Home
  • Entertainment
  • Sports
  • About Us
  • Bangladesh
  • International
  • Privacy Policy
  • Comment Policy
  • Contact Us
  • Economy
  • Sitemap
  • RSS

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net

Copyright © 2022 THE BUSINESS STANDARD All rights reserved. Technical Partner: RSI Lab